Several studies and meta-analyses have confirmed the correlation between PD-L1 expression and KRAS status in NSCLC [32,33,34,35], but conflicting studies reported that expression of PD-L1 was varied according to the pattern of downstream signaling [36,37]. The gene discussed is CD274; the disease is non-small cell lung carcinoma.